Policy | 06 September 2026
India must build resilient, globally integrated healthcare supply chains: Commerce Minister Piyush Goyal
Pharma sector must lead in R&D, new molecules, biosimilars and biotech
Pharma sector must lead in R&D, new molecules, biosimilars and biotech
According to figures shared during the Mumbai engagement, Gujarat accounts for around 18% of India's pharmaceutical sector, while the state has a 16% share in pharmaceutical manufacturing
Planned as a recurring platform, the future editions are proposed across different cities to connect regional biotechnology innovation ecosystems with investment networks
The company remains in active negotiations with the Trump Administration and is seeking a deal built around all four of President Trump’s drug-pricing priorities
Health Ministry reviews malaria elimination strategy with focus now on remaining 33 high-burden districts to achieve SDG target of ending malaria by 2030
Indian Pharmacopoeia Commission introduces seven phytochemical and five botanical reference standards at Northeast conclave
Rs. 5,000-crore scheme invites applications from startups, MSMEs and industry across new medicines, biosimilars, novel medical devices and other priority areas
The union minister highlighted India's growing role in global healthcare and the potential of artificial intelligence (AI) to transform drug discovery, diagnostics and patient care
The conference provided a platform for knowledge sharing, networking and collaboration aimed at promoting a ‘whole-of-government’ approach and reducing organisational silos
Health Ministry reviews ILI/SARI trends, testing, hospital capacity and critical-care readiness in Delhi and across India
The state has has more than 20 dedicated life sciences incubators supporting over 1,000 startups, alongside research capabilities, global capability centres, manufacturing infrastructure and a deep talent pool
Calling for the creation of brands that attract the world, Modi said Indian brands should become a strong representation of the country and strengthen India’s identity as a global destination
New unified authority aims to strengthen regulatory oversight and enforcement under the Food Safety and Standards Act and Drugs and Cosmetics Act, as state moves to curb spurious and substandard products
The consultation brought together parliamentarians from both states across party lines and focused on strengthening political leadership, community participation and last-mile delivery of TB services
The event on August 21, 2026 has been designed to exchange best practices, discuss emerging workforce trends and contribute to shaping India’s national skilling agenda for the life sciences sector
The knowledge paper points to fragmented health data, limited clinical evidence and the absence of predictable lifecycle-based regulation for adaptive AI as key barriers to wider adoption
India Medical Device 2026 highlights the need for deeper domestic value addition, advanced manufacturing, predictable regulation and stronger industry-startup collaboration
ICMR, CSIR and DBT actively promoting and strengthening the use of advanced in-vitro, cell-based, three-dimensional tissue models and computational methods
The ministry has incorporated procedural safeguards, including the issuance of a show-cause notice before any debarment order is passed
Anil Matai, Director General, OPPI calls for structured and regular engagement between regulators and industry to strengthen trust, transparency, and collaboration within India’s pharma regulatory ecosystem
Subscribe To Our Newsletter & Stay Updated
